Trade name: Tamiflu
Generic names: oseltamivir phosphate
Indication and Usage | FDA has approved this antiviral medication indicated for: treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours as well as prophylaxis of influenza A and B in patients 1 year and older.
Ingredients | Active ingredient: oseltamivir phosphate
Inactive ingredients:
TAMIFLU capsules: croscarmellose sodium, povidone K30, pregelatinized starch, sodium stearyl fumarate, and talc
30mg capsule shell: gelatin, red iron oxide, titanium dioxide, and yellow iron oxide
45mg capsules shell: black iron oxide, gelatin, and titanium dioxide
75mg capsules shell: black iron oxide, gelatin, red iron oxide, titanium dioxide, and yellow iron oxide
TAMIFLU for oral suspension: monosodium citrate, saccharin sodium, sodium benzoate, sorbitol, titanium dioxide, tutti-frutti flavoring, and xanthan gum.
Manufacturer-listed adverse reactions | Tamiflu cause: Swelling of the face or tongue, Allergy, Anaphylactic/anaphylactoid reactions, Hypothermia, Rash, Dermatitis, Urticaria, Eczema, Toxic epidermal necrolysis, Stevens-Johnson Syndrome, Erythema multiforme, Hepatitis, Liver function tests abnormal, Arrhythmia (irregular heartbeat), Gastrointestinal bleeding, Hemorrhagic colitis (bleeding colon or large intestine), Seizure, Aggravation of diabetes, Abnormal behavior, Delirium including symptoms such as hallucinations, agitation, anxiety, altered level of consciousness, confusion, nightmares, and delusions, Nausea, Vomiting, Diarrhea, and Abdominal pain
Need more info? Click the link below for a helpful infographic you can view + save on your device.
For Tamiflu alternatives, please visit the Flu webpage.